Teleflex Inc

Teleflex Inc. Reports Mixed Q1 Results, Achieves FDA Milestone for Hemostatic Device

Teleflex Inc. reported mixed financial results for Q1 2025, with revenue declining 3.8% but non-GAAP EPS exceeding expectations, amidst regulatory milestones and strategic initiatives.

Teleflex Inc
Health Care
Health Care Equipment & Services
AI generated

2025-05-01

3 minutes to read

FDA Approves Expanded Use of Teleflex’s QuikClot Control+ for Broader Bleeding Control Applications

Teleflex Inc. has received FDA clearance for its QuikClot Control+ device, allowing it to be used for all grades of internal and external bleeding, expanding its application in various medical procedures.

Teleflex Inc
Health Care
Health Care Equipment & Services
AI generated

2025-04-30

2 minutes to read